HSP90B1 and liver cancer: Using a genetic strategy, depletion of GRP94 from specific cells reveals that GRP94 promotes tumorigenesis in multiple myeloma (10), liver cancer (20–22), colon cancer (23, 24), and endometrial carcinoma (25).